Loading...
Recent reports of increased risk for late stent thrombosis in the treatment of coronary artery disease with drug-eluting stents (DES) have prompted physicians to reduce the use of this device and increase the use of bare metal stents (BMS). Now, investigators have used population-based data from a large registry in western Denmark to compare outcomes with both devices at 15 months. A total of 12,395 consecutive patients underwent a percutaneous coronary intervention with either BMS (8847 patients, 11,730 lesions) or DES (3548 patients, 5422 lesions). Patients treated with BMS were older, less likely to have diabetes, and more likely to have ST-segment-elevation MI (STEMI) than those treated with DES. Patients treated with DES had more comor…